You are here: Industry Insights > Pharmaceuticals

News List

The 20 most expensive pharmacy drugs in 2018, featuring names big and small fiercepharma
January 02, 2019
More and more, specialty drugs carrying eye-popping price tags are winning FDA approvals.
Bayer Group Restructures contractpharma
December 03, 2018
Will result in the reduction of approximately 12,000 jobs worldwide by the end of 2021
Ascendis Pharma announces formation of VISEN Pharmaceuticals biospectrumasia
November 19, 2018
The new company aims to develop, manufacture and commercialize the companys endocrinology rare disease therapies in Grea
Ascendis Pharma announces formation of VISEN Pharmaceuticals biospectrumasia
November 14, 2018
The new company aims to develop, manufacture and commercialize the company’s endocrinology rare disease therapies in Greater China, which includes mainland China, Hong Kong, S.A.R., China, Macau, S.A.R., China and Taiwan, China
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock pharmafile
November 12, 2018
REDWOOD CITY, Calif., Nov. 9, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) today announced the pricing of its previously announced underwritten public
Cumberland Pharmaceuticals to Acquire Vibativ americanpharmaceuticalreview
November 07, 2018
Cumberland Pharmaceuticals to Acquire Vibativ
Days after Alexion deal, Dicerna pens $100M upfront RNAi research pact with Eli Lilly fiercebiotech
November 02, 2018
Fresh off a deal with Alexion last week, Dicerna has started off this week with another deal: This time with Eli Lilly.
Aerie Pharmaceuticals Launches GMP Facility contractpharma
October 30, 2018
Aerie Pharmaceuticals Launches GMP Facility
Synergy Pharmaceuticals' shares plunge as buyout offers fall short of market value firstwordpharma
October 29, 2018
Synergy Pharmaceuticals' shares plunge as buyout offers fall short of market value
Mesoblast Expands Partnership With JCR Pharmaceuticals for Treatment of Wound Healing in Epidermolysis Bullosa firstwordpharma
October 25, 2018
Mesoblast Expands Partnership With JCR Pharmaceuticals for Treatment of Wound Healing in Epidermolysis Bullosa

Previous page 1 2 3 4 5 6 7 Next page